Nuformix plc (LON:NFX – Get Free Report)’s share price fell 11.1% during mid-day trading on Wednesday . The company traded as low as GBX 0.08 ($0.00) and last traded at GBX 0.08 ($0.00). 13,393,661 shares were traded during mid-day trading, a decline of 78% from the average session volume of 62,280,551 shares. The stock had previously closed at GBX 0.09 ($0.00).
Nuformix Trading Down 11.1 %
The firm’s fifty day simple moving average is GBX 0.07 and its 200 day simple moving average is GBX 0.08. The company has a market cap of £985,447.27, a price-to-earnings ratio of -2.43 and a beta of 1.22.
Nuformix (LON:NFX – Get Free Report) last issued its earnings results on Wednesday, January 29th. The company reported GBX (0.46) (($0.01)) EPS for the quarter.
About Nuformix
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.
Further Reading
- Five stocks we like better than Nuformix
- Conference Calls and Individual Investors
- Lemonade’s Q4 Surge: Has This AI-Powered Insurer Turned a Corner?
- What is the Hang Seng index?
- 2 Energy Stocks to Play Both Sides of Tariff Uncertainty
- Using the MarketBeat Dividend Tax Calculator
- Raytheon vs. Lockheed Martin: Which Stock Has More Upside?
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
